Delivering Scientific and Service Excellence for 10 Years

28th September 2017

Category: General

Tags: , , , , , ,


In 2007, a team of experienced industry professionals founded BioOutsource Ltd. in Glasgow, UK. This year we are celebrating our 10 year anniversary, and taking a look back at our key milestones and achievements. Follow our story about how we began as a small start-up business to becoming one of the global leaders in contract testing.

August 2007

  • BioOutsource Ltd. was founded
  • The company was set up to address customer service level issues in the industry, offering excellent customer service as well as scientific expertise.

May 2008

  • BioOutsource Ltd. receieved MHRA approval and GMP certification.

February 2009

  • BioOutsource Ltd. was awarded the most promising new life science company in Scotland at the annual Scottish Enterprise Life Sciences Awards ceremony.

March 2012

  • Laboratory space was doubled at the West of Scotland Science Park in Glasgow, as we continued to grow and offer more services.

September 2013

  • Utilising our expertise in bioanalytical testing of innovator biologics, BioOutsource Ltd. pioneered the development of off-the-shelf assays to support biosimilar characterization and comparibility.
  • A full range of services was launched in September 2013 for the top 6 blockbuster monochlonal antibodies. Something we have been adding to ever since.

June 2014

  • PsiOxus Therapeutics Ltd. select BioOutsource to support clinical sampling analysis of its Phase I / II OCTAVE ovarian cancer study.

February 2015

  • Due to the global demand for our biosimilar testing services, BioOutsource Ltd. expanded its footprint with a new Biosimilar Centre of Excellence building, doubling our capacity for bioanalytical testing.

April 2015 

  • BioOutsource Ltd. was acquired by Sartorius Stedim Biotech to strengthen and develop SSB’s service offering throughout the drug development pathway.

July 2015

  • Sartorius Stedim BioOutsource Ltd. opens new facility in Glasgow, UK to increase capacity for bioanalytical testing of biologics and biosimilars

March 2016

  • Sartorius Stedim BioOutsource Ltd. Glasgow facility successfully passes inspection by the U.S. Food and Drug Administration (FDA). Not a single Form 483 observation for non-conformance was issued.

April 2016

  • Sartorius Stedim BioOutsource double workforce due to increasing demand for its contract testing services.

June 2016

  • Sartorius Stedim BioOutsource incorporates Sartorius Stedim Cellca’s services and products onto its website to position the integrated early stage development services offered by Sartorius Stedim Biotech to the market.

July 2016

  • Sartorius Stedim BioOutsource expands service offering to include N-glycan analysis for in-depth profiling of IgG glycosylation.

November 2016

  • Sartorius Stedim Biotech opens new laboratory in Cambridge, MA, USA to enable U.S. biopharmaceutical companies to easily access BioOutsource bioanalytical and biosafety testing services.

April 2017

  • Sartorius Stedim BioOutsource are named as Scottish Life Sciences Company of the year at the Made in Scotland awards. We were recognised for our innovative services and ability to make an impact on the in the markets we serve, both domestically and internationally.

May 2017

July 2017

  • Sartorius Stedim BioOutsource was awarded the European Bioanalytical Contract Testing Services Customer Service Leadership award for our pioneering off-the-shelf methods, thought leadership and commitment to delivering service excellence.

We look forward to continuing to deliver scientific excellence and world class customer service as part of Sartorius Stedim Biotech.

Talk to one of our scientific experts about your testing requirements.
Contact us

Sign-up to our newsletter to be the first to hear about our new services & offers

Sign-up to our newsletter to be the first to hear about our new services & offers

Enter your email address to subscribe to our newsletter which provides information about our services. By subscribing, you are agreeing to the processing of your personal information for this purpose as set out in our privacy policy